Publications by authors named "Jonathan Oh"

Claim this Profile
C
Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, John Nemunaitis

Gynecol Oncol Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rodney P Rocconi, Elizabeth A Grosen, Sharad A Ghamande, John K Chan, Minal A Barve, Jonathan Oh, John Nemunaitis

Lancet Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
Jonathan Oh, Minal Barve, Carolyn M Matthews, E Colin Koon, Thomas P Heffernan, John Nemunaitis

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective and Reversible Binding of Thiol-Functionalized Biomolecules on Polymers Prepared via Chemical Vapor Deposition Polymerization.
Aftin Ross, Hakan Durmaz, Kenneth Cheng, Xiaopei Deng, Yuwei Liu, Jonathan Oh

Langmuir· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.
Neil Senzer, Minal Barve, Joseph Kuhn, Anton Melnyk, Peter Beitsch, Jonathan Oh, Zhaohui Wang, John Nemunaitis

Mol Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive endometrial lesion in a patient with mental retardation.
Jonathan Oh, Mala Karunanayake, C Allen Stringer

Proc (Bayl Univ Med Cent)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma.
Sergio Martínez-Román, Pedro T Ramirez, Jonathan Oh, Marcelo Gonzalez Viciedo, Homer A MacApinlac

Gynecol Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for young premenopausal women with endometrial cancer.
Pamela T Soliman, Jonathan C Oh, Kathleen M Schmeler, Charlotte C Sun, Brian M Slomovitz

Obstet Gynecol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
Brian M Slomovitz, Russell R Broaddus, Rosemarie Schmandt, Weiguo Wu, Jonathan C Oh

Gynecol Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Pamela T Soliman, Brian M Slomovitz, Russell R Broaddus, Charlotte C Sun, Jonathan C Oh

Gynecol Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Jonathan C Oh, Weiguo Wu, Guillermo Tortolero-Luna, Russell Broaddus, David M Gershenson

Cancer Epidemiol Biomarkers Prev· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
Brian M Slomovitz, Thomas W Burke, Patricia J Eifel, Lois M Ramondetta, Elvio G Silva, Jonathan C Oh

Gynecol Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis